198 related articles for article (PubMed ID: 30411254)
1. Prostaglandin E
Wang M; Wang Y; Xie T; Zhan P; Zou J; Nie X; Shao J; Zhuang M; Tan C; Tan J; Dai Y; Sun J; Li J; Li Y; Shi Q; Leng J; Wang X; Yao Y
Diabetologia; 2019 Feb; 62(2):335-348. PubMed ID: 30411254
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Xie T; Zhang Z; Cui Y; Shu Y; Liu Y; Zou J; Wang M; Wang Y; Yang Q; Pan X; Cai J; Sun X; Yao Y; Wang X
Exp Eye Res; 2021 Apr; 205():108507. PubMed ID: 33609510
[TBL] [Abstract][Full Text] [Related]
3. AH6809 decreases production of inflammatory mediators by PGE
Li P; Jiang H; Wu H; Wu D; Li H; Yu J; Lai J
Brain Res; 2018 Nov; 1698():11-28. PubMed ID: 29792868
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
5. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 Activates NLRP3 Inflammasome in Endothelial Cells to Promote Diabetic Retinopathy.
Wang Y; Tao J; Yao Y
Horm Metab Res; 2018 Sep; 50(9):704-710. PubMed ID: 30142638
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
8. ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes.
Li T; Hu J; Du S; Chen Y; Wang S; Wu Q
Mol Vis; 2014; 20():1109-21. PubMed ID: 25324681
[TBL] [Abstract][Full Text] [Related]
9. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E
Li H; Chen HY; Liu WX; Jia XX; Zhang JG; Ma CL; Zhang XJ; Yu F; Cong B
Immunol Lett; 2017 Nov; 191():63-72. PubMed ID: 28963072
[TBL] [Abstract][Full Text] [Related]
12. Proliferation of bovine endometrial epithelial cells is promoted by prostaglandin E
Liu B; Fu C; Cao J; Mao W; Zhang S; Li Q; Zhao J; Feng S
Prostaglandins Leukot Essent Fatty Acids; 2021 Nov; 174():102362. PubMed ID: 34740034
[TBL] [Abstract][Full Text] [Related]
13. Role of hypoxia-inducible factor 1, α subunit and cAMP-response element binding protein 1 in synergistic release of interleukin 8 by prostaglandin E2 and nickel in lung fibroblasts.
Brant KA; Fabisiak JP
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):105-13. PubMed ID: 23526216
[TBL] [Abstract][Full Text] [Related]
14. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 facilitates neurite outgrowth in a motor neuron-like cell line, NSC-34.
Nango H; Kosuge Y; Miyagishi H; Sugawa K; Ito Y; Ishige K
J Pharmacol Sci; 2017 Oct; 135(2):64-71. PubMed ID: 28966102
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 induces apoptosis in cultured rat microglia.
Nagano T; Kimura SH; Takemura M
Brain Res; 2014 Jun; 1568():1-9. PubMed ID: 24845544
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
19. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC.
Li R; Mouillesseaux KP; Montoya D; Cruz D; Gharavi N; Dun M; Koroniak L; Berliner JA
Circ Res; 2006 Mar; 98(5):642-50. PubMed ID: 16456101
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
